Pharm Sci. 2020;26(Suppl 1): S49-S51.
doi: 10.34172/PS.2020.41

Scopus ID: 85097290006
  Abstract View: 319
  PDF Download: 246


Mini Review

NSAIDs and COVID-19: A New Challenging Area

Hananeh Baradaran 1 ORCID logo, Hadi Hamishehkar 2, Haleh Rezae 2* ORCID logo

1 Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
2 Department of Clinical Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.


Considering the recent controversies regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Coronavirus disease 2019 (COVID-19) patients, and due to the limited published data in this field, we reviewed currently available evidence for the use of NSAIDs in viral respiratory tract infections to help make decisions in this area. Currently, there is insufficient
evidence to judge the safety and efficacy of NSAIDs in patients with COVID-19. According to the current evidence, acetaminophen is the choice treatment for symptomatic relief. If the patients’ symptoms are not controlled by acetaminophen, naproxen may be used as an alternative therapy.
Keywords: NSAIDs, COVID-19, Patients
First Name
Last Name
Email Address
Security code

Abstract View: 259

Your browser does not support the canvas element.

PDF Download: 246

Your browser does not support the canvas element.

Submitted: 31 Mar 2020
Accepted: 19 May 2020
ePublished: 30 Nov 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)